Eribulin Mesylate 68083-0592-01

Package NDC

68083-0592-01

Manufacturer: Gland Pharma Limited
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: April 5, 2024
Listing Expires: December 31, 2026
Application: ANDA218047

Need to source Eribulin Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Eribulin Mesylate	.5 mg/mL

Drug Class

Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Selected Package

68083-0592-01Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (68083-592-01) / 2 mL in 1 VIAL, SINGLE-DOSE